Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 329

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Vitamin D status is associated with relapse rate in pediatric‐onset multiple sclerosis

Mowry, Ellen M., Krupp, Lauren B., Milazzo, Maria, Chabas, Dorothee, Strober, Jonathan B., Belman, Anita L., McDonald, Jamie C., Oksenberg, Jorge R., Bacchetti, Peter, Waubant, Emmanuelle·2010·Annals of Neurology

Abstract

Objective: We sought to determine if vitamin D status, a risk factor for multiple sclerosis, is associated with the rate of subsequent clinical relapses in pediatric‐onset multiple sclerosis. Methods: This is a retrospective study of patients with pediatric‐onset multiple sclerosis or clinically isolated syndrome who were consecutively recruited into a prospective cohort at their clinical visit at the pediatric multiple sclerosis center of University of California, San Francisco or State University of New York at Stony Brook. Of 171 eligible patients, 134 (78%) with multiple sclerosis/clinically isolated syndrome were included in the cohort; a further 24 were excluded from this analysis due to lack of available serum (n = 7) or lack of follow‐up (n = 17). Serum 25‐hydroxyvitamin D 3 levels were measured and were adjusted to reflect a deseasonalized value. The adjusted serum 25‐hydroxyvitamin D 3 level was the primary predictor in a multivariate negative binomial regression model in which the main outcome measure was the number of subsequent relapses. Results: Among the 110 subjects, the mean unadjusted 25‐hydroxyvitamin D 3 level was 22 ± 9ng/ml. After adjustment for age, gender, race, ethnicity, disease duration, disease‐modifying therapy, and length of follow‐up, every 10ng/ml increase in the adjusted 25‐hydroxyvitamin D 3 level was associated with a 34% decrease in the rate of subsequent relapses (incidence rate ratio, 0.66; 95% confidence interval, 0.46–0.95; p = 0.024). Interpretation: Lower serum 25‐hydroxyvitamin D 3 levels are associated with a substantially increased subsequent relapse rate in pediatric‐onset multiple sclerosis or clinically isolated syndrome, providing rationale for a randomized controlled trial of vitamin D supplementation. ANN NEUROL 2010;67:618–624

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.21972

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 329

Metadata

Authors
Mowry, E. M., Krupp, L. B., Milazzo, M., Chabas, D., Strober, J. B., Belman, A. L., McDonald, J. C., Oksenberg, J. R., Bacchetti, P., & Waubant, E.
Venue
Annals of Neurology
Publisher
Wiley
Published
2010-04-26
Volume
67
Issue
5
Pages
618-624
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W1606806706
Cited by
329
References
1
FWCI
23.27
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vitamin D status is associated with relapse rate in pediatric‐onset multiple sclerosis. https://app.cochat.ai/papers/10.1002/ana.21972
The paper
Mowry, E. M., Krupp, L. B., Milazzo, M., Chabas, D., Strober, J. B., Belman, A. L., McDonald, J. C., Oksenberg, J. R., Bacchetti, P., & Waubant, E. (2010). Vitamin D status is associated with relapse rate in pediatric‐onset multiple sclerosis. Annals of Neurology. https://doi.org/10.1002/ana.21972

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.